HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Patrizia Agostinis Selected Research
Patrizia Agostinis Research Topics
Disease
89
Neoplasms (Cancer)
01/2022 - 03/2002
15
Melanoma (Melanoma, Malignant)
01/2021 - 01/2013
7
Hypoxia (Hypoxemia)
04/2018 - 01/2006
6
Carcinogenesis
01/2018 - 09/2007
6
Urinary Bladder Neoplasms (Bladder Cancer)
01/2017 - 08/2004
6
Necrosis
12/2011 - 03/2002
5
Glioblastoma (Glioblastoma Multiforme)
01/2022 - 03/2011
5
Inflammation (Inflammations)
01/2022 - 01/2006
4
Neoplasm Metastasis (Metastasis)
01/2016 - 01/2012
3
Parkinson Disease (Parkinson's Disease)
01/2022 - 07/2015
3
Sunburn
09/2010 - 12/2004
2
Ovarian Neoplasms (Ovarian Cancer)
11/2021 - 09/2015
2
Rupture
12/2020 - 01/2020
2
Starvation
01/2020 - 12/2011
2
Glioma (Gliomas)
03/2016 - 02/2016
2
Kufor-Rakeb syndrome
01/2016 - 07/2015
2
Skin Neoplasms (Skin Cancer)
01/2013 - 12/2010
2
Photosensitivity Disorders (Photodermatitis)
12/2011 - 11/2009
2
Carcinoma (Carcinomatosis)
12/2010 - 08/2004
2
Transitional Cell Carcinoma
06/2005 - 08/2004
1
Alzheimer Disease (Alzheimer's Disease)
01/2022
1
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022
1
Mitochondrial Diseases (Mitochondrial Disease)
01/2022
1
Brain Neoplasms (Brain Tumor)
01/2022
1
Proteostasis Deficiencies
01/2022
1
Virus Diseases (Viral Diseases)
12/2021
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1
Pulmonary Arterial Hypertension
01/2021
1
Pain (Aches)
12/2020
1
Hypersensitivity (Allergy)
12/2020
1
COVID-19
01/2020
1
Bites and Stings (Sting)
01/2019
1
Pancreatic Neoplasms (Pancreatic Cancer)
01/2018
Drug/Important Bio-Agent (IBA)
28
1-phenyl-3,3-dimethyltriazene (PDT)
IBA
11/2016 - 03/2002
15
hypericin
IBA
11/2016 - 03/2002
11
Proteins (Proteins, Gene)
FDA Link
01/2021 - 05/2009
11
Vaccines
IBA
01/2020 - 01/2010
10
Reactive Oxygen Species (Oxygen Radicals)
IBA
03/2016 - 10/2003
9
Pharmaceutical Preparations
IBA
01/2018 - 03/2002
8
Photosensitizing Agents (Photosensitizers)
IBA
09/2012 - 03/2002
7
Cytokines
IBA
01/2022 - 09/2010
7
Adenosine Triphosphate (ATP)
IBA
12/2020 - 03/2012
7
Calreticulin
IBA
01/2017 - 02/2012
6
Chloroquine (Aralen)
FDA Link
Generic
01/2019 - 01/2012
6
Oxygen (Dioxygen)
IBA
01/2018 - 03/2002
5
Biomarkers (Surrogate Marker)
IBA
11/2021 - 02/2015
5
Antigens
IBA
01/2019 - 12/2014
5
Enzymes
IBA
02/2015 - 12/2003
4
Chemokines
IBA
01/2022 - 09/2010
4
Immune Checkpoint Inhibitors
IBA
01/2018 - 01/2017
4
Antioxidants
IBA
02/2016 - 04/2007
4
p38 Mitogen-Activated Protein Kinases
IBA
02/2014 - 12/2003
3
Phosphotransferases (Kinase)
IBA
01/2022 - 03/2012
3
Iron
IBA
12/2021 - 01/2021
3
Polyamines
IBA
01/2021 - 01/2020
3
Transcription Factors (Transcription Factor)
IBA
01/2020 - 08/2011
3
Lipids
IBA
01/2020 - 07/2015
3
Purinergic Receptors (Receptors, Purine)
IBA
01/2018 - 01/2017
3
Melphalan (Alkeran)
FDA Link
Generic
12/2015 - 04/2015
3
Interleukin-6 (Interleukin 6)
IBA
04/2015 - 09/2013
3
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
04/2005 - 12/2003
2
KIRA6
IBA
01/2022 - 12/2020
2
Interferons
IBA
11/2021 - 10/2013
2
Hydroxychloroquine (Plaquenil)
FDA Link
Generic
01/2020 - 01/2017
2
Glucose (Dextrose)
FDA Link
Generic
01/2019 - 02/2015
2
Pattern Recognition Receptors
IBA
01/2019 - 12/2012
2
Mitoxantrone (Novantrone)
FDA Link
Generic
04/2018 - 09/2015
2
Plastics
IBA
01/2018 - 01/2016
2
Coloring Agents (Dyes)
IBA
01/2013 - 06/2010
2
Flavonoids
IBA
01/2012 - 09/2010
2
Luteolin
IBA
01/2012 - 09/2010
2
Acids
IBA
12/2011 - 03/2011
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2005 - 04/2005
1
Chemotactic Factors
IBA
01/2022
1
diazonaphthalenedisulfonic acid (NDS)
IBA
01/2022
1
Hypoxia-Inducible Factor 1
IBA
01/2021
1
Mitoguazone (MGBG)
IBA
01/2021
1
Ribonucleases (Ribonuclease)
IBA
12/2020
1
MitoTEMPO
IBA
12/2020
1
Spermine
IBA
12/2020
1
Rotenone
IBA
12/2020
1
Platinum
IBA
09/2020
1
Cathepsin B
IBA
01/2020
1
Toll-Like Receptors (Toll-Like Receptor)
IBA
01/2019
1
Tunicamycin
IBA
01/2019
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2019
1
Tricarboxylic Acids
IBA
01/2019
1
Phosphoproteins
IBA
01/2019
1
Ligands
IBA
01/2019
1
trametinib
IBA
01/2019
1
Interferon Type I
IBA
01/2019
1
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
01/2019
1
Glutamine (L-Glutamine)
FDA Link
01/2019
1
Alarmins
IBA
11/2017
1
Pathogen-Associated Molecular Pattern Molecules
IBA
11/2017
Therapy/Procedure
42
Therapeutics
01/2022 - 12/2003
20
Photochemotherapy (Photodynamic Therapy)
09/2015 - 03/2002
19
Immunotherapy
11/2021 - 12/2014
8
Drug Therapy (Chemotherapy)
01/2022 - 12/2010
2
Radiotherapy
01/2019 - 09/2015